March 2, 2020 / 6:30 AM / a month ago

BRIEF-Acacia Pharma FY Loss After Tax Widens To USD 22.8 Mln

March 2 (Reuters) - ACACIA PHARMA GROUP PLC:

* RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019

* LOSS AFTER TAX FOR YEAR ENDED 31 DECEMBER 2019 $22.8M (2018: $20.7M)

* CASH AND CASH EQUIVALENTS AS AT 31 DECEMBER 2019 $17.0M (2018: $37.4M)

* ADDITION OF RIGHTS TO BYFAVO, EQUITY INVESTMENT AND DEBT AVAILABILITY HAS SIGNIFICANTLY ENHANCED GROUP’S RESOURCES AND ABILITY TO DELIVER LONG-TERM VALUE FOR SHAREHOLDERS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below